Therapeutic compounds for treating dyslipidemic conditions
申请人:Jones Brian A.
公开号:US20050239769A1
公开(公告)日:2005-10-27
The present invention relates to novel LXR ligands of Formula I and the pharmaceutically acceptable salts, esters and tautomers thereof, which are useful in the treatment of dyslipidemic conditions, particularly depressed levels of HDL cholesterol.